{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:57:38Z","timestamp":1790816258799,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Familial partial lipodystrophy (FPLD) is a rare inherited disorder characterized by selective loss of subcutaneous fat and severe metabolic complications. Eight subtypes of FPLD have been described to date, most of which are caused by variants in genes involved in adipocyte differentiation and lipid metabolism. The most common form, FPLD type 2, is caused by heterozygous variants in the\n                    <jats:italic>LMNA<\/jats:italic>\n                    gene, whereas much rarer forms, such as FPLD type 6, are associated with biallelic variants in\n                    <jats:italic>LIPE<\/jats:italic>\n                    . Here, we describe five patients carrying novel or ultrarare pathogenic variants in\n                    <jats:italic>LMNA<\/jats:italic>\n                    (p.Lys117Arg, p.Asn195Tyr, p.Ser239Arg, p.Lys515Glu) and\n                    <jats:italic>LIPE<\/jats:italic>\n                    (homozygous p.Val1068GlyfsTer102), thereby expanding the known genetic and phenotypic spectrum of FPLD. All individuals exhibited abnormal fat distribution and metabolic disturbances, with considerable interindividual variability in the extent and pattern of adipose tissue loss and accumulation.\n                    <jats:italic>LMNA<\/jats:italic>\n                    -related cases showed cardiac involvement, whereas the\n                    <jats:italic>LIPE<\/jats:italic>\n                    -related case presented peculiar patterns of fat redistribution and specific clinical features. These findings underscore the importance of genetic testing in patients with otherwise unexplained lipodystrophy to facilitate early diagnosis, guide personalized management, enable family screening, and support long-term multidisciplinary follow-up for monitoring metabolic, cardiovascular, and systemic complications.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2026.1725771","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:00:51Z","timestamp":1772625651000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Familial partial lipodystrophy, description of novel and ultrarare variants with distinct phenotypic spectrum"],"prefix":"10.3389","volume":"17","author":[{"given":"Silvia","family":"Magno","sequence":"first","affiliation":[{"name":"Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Pelosini","sequence":"additional","affiliation":[{"name":"Chemistry and Endocrinology Laboratory, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Paoli","sequence":"additional","affiliation":[{"name":"Chemistry and Endocrinology Laboratory, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Gilio","sequence":"additional","affiliation":[{"name":"Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Palladino","sequence":"additional","affiliation":[{"name":"Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Menconi","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Barison","sequence":"additional","affiliation":[{"name":"Cardiology Division, Fondazione Toscana Gabriele Monasterio","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Todiere","sequence":"additional","affiliation":[{"name":"Cardiology Division, Fondazione Toscana Gabriele Monasterio","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ortori","sequence":"additional","affiliation":[{"name":"Diagnostic and Interventional Radiology Unit, Pisa University Hospital","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Coco","sequence":"additional","affiliation":[{"name":"Hepatology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano","family":"Paolucci","sequence":"additional","affiliation":[{"name":"Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Salvetti","sequence":"additional","affiliation":[{"name":"Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"Sessa","sequence":"additional","affiliation":[{"name":"Chemistry and Endocrinology Laboratory, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ceccarini","sequence":"additional","affiliation":[{"name":"Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferruccio","family":"Santini","sequence":"additional","affiliation":[{"name":"Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: Findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0447","article-title":"Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort","volume":"69","author":"Gonzaga-Jauregui","year":"2020","journal-title":"Diabetes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0887-z","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11892-025-01602-5","article-title":"Lipodystrophy syndromes: one name but many diseases highlighting the importance of adipose tissue in metabolism","volume":"25","author":"Foss-Freitas","year":"2025","journal-title":"Current Diabetes Reports"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102287","article-title":"Ultrasound methods for the assessment of liver steatosis: A critical appraisal","volume":"12","author":"Bozic","year":"2022","journal-title":"Diagnostics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.1.59","article-title":"Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of missense mutations in lamin A\/C gene","volume":"86","author":"Garg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-104437","article-title":"LMNA-associated partial lipodystrophy: Anticipation of metabolic complications","volume":"54","author":"Jeru","year":"2017","journal-title":"J Med Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad606","article-title":"Deciphering the clinical presentations in LMNA-related lipodystrophy: report of 115 cases and a systematic review","volume":"109","author":"Besci","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051142","article-title":"Partial lipodystrophy and lmna p.R545h variant","volume":"10","author":"Magno","year":"2021","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3892\/mmr.2024.13358","article-title":"Advances in research on the relationship between the LMNA gene and human diseases (Review)","volume":"30","author":"Zhao","year":"2024","journal-title":"Mol Med Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-016-0365-2","article-title":"Limb-girdle muscular dystrophy with severe heart failure overlapping with lipodystrophy in a patient with LMNA mutation p.Ser334del","volume":"58","author":"Madej-Pilarczyk","year":"2017","journal-title":"J Appl Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.114.24.4447","article-title":"Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy","volume":"114","author":"Raharjo","year":"2001","journal-title":"J Cell Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1006\/jsbi.1998.3987","article-title":"Nuclear lamins: Their structure, assembly, and interactions","volume":"122","author":"Stuurman","year":"1998","journal-title":"J Struct Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf091","article-title":"Genetics evaluation outcomes from an academic multidisciplinary atypical diabetes program","volume":"9","author":"Chase","year":"2025","journal-title":"J Endocr Soc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-2126(02)00777-3","article-title":"The Ig-like structure of the C-terminal domain of lamin A\/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy","volume":"10","author":"Krimm","year":"2002","journal-title":"Structure"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2013.12.008","article-title":"LMNA gene mutation as a model of cardiometabolic dysfunction: From genetic analysis to treatment response","volume":"40","author":"Chirico","year":"2014","journal-title":"Diabetes Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf279","article-title":"Novel and ultrarare heterozygous missense LMNA variants causing familial partial lipodystrophy","author":"Anum","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa104","article-title":"Multisystem progeroid syndrome with lipodystrophy, cardiomyopathy, and nephropathy due to an LMNA p.R349W variant","volume":"4","author":"Hussain","year":"2020","journal-title":"J Endocr Soc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa108","article-title":"Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation","volume":"4","author":"Magno","year":"2020","journal-title":"J Endocr Soc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1032653","article-title":"Case report: Focal segmental glomerulosclerosis in a pediatric atypical progeroid syndrome","volume":"10","author":"Jang","year":"2022","journal-title":"Front Pediatr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2012.06.013","article-title":"CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers","volume":"6","author":"Fontana","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2017.00079","article-title":"LMNA sequences of 60,706 unrelated individuals reveal 132 novel missense variants in A-type lamins and suggest a link between variant p.G602S and type 2 diabetes","volume":"8","author":"Florwick","year":"2017","journal-title":"Front Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030765","article-title":"Looking at new unexpected disease targets in LMNA-linked lipodystrophies in the light of complex cardiovascular phenotypes: implications for clinical practice","volume":"9","author":"Mosbah","year":"2020","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32811e16fb","article-title":"The role of neutral lipases in human adipose tissue lipolysis","volume":"18","author":"Arner","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1315496","article-title":"Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes","volume":"370","author":"Albert","year":"2014","journal-title":"New Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24157","article-title":"Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin","volume":"49","author":"Carboni","year":"2014","journal-title":"Muscle Nerve"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.09.007","article-title":"A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partialLipodystrophy","volume":"30","author":"Farhan","year":"2014","journal-title":"Can J Cardiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37880","article-title":"Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy","volume":"173","author":"Zolotov","year":"2017","journal-title":"Am J Med Genet A"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1013","article-title":"LIPE-related lipodystrophic syndrome: Clinical features and disease modeling using adipose stem cells","volume":"184","author":"Sollier","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1417613","article-title":"Case report: First Chinese patient with family partial lipodystrophy type 6 due to novel compound heterozygous mutations in the LIPE gene","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.59556\/japi.73.0932","article-title":"Interesting case of familial partial lipodystrophy syndrome (Type 6) with LIPE gene defect: A case report","volume":"73","author":"Mohan","year":"2025","journal-title":"J Assoc Physicians India"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02308-3","article-title":"Serum levels of adiponectin differentiate generalized lipodystrophies from anorexia nervosa","volume":"47","author":"Ceccarini","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-1295-y","article-title":"European lipodystrophy registry: Background and structure","volume":"15","author":"Von Schnurbein","year":"2020","journal-title":"Orphanet J Rare Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1725771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:00:52Z","timestamp":1772625652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1725771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":34,"alternative-id":["10.3389\/fendo.2026.1725771"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1725771","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1725771"}}